CURRENT ISSUE Current Issue Cover
VOL 9 • NO 1 JAN/FEB 2018
IN THIS ISSUE

It’s Just the Flu…or Is It?

Pamela Hallquist Viale, RN, MS, CNS, ANP

Oncology Nurse Practitioner
 Web Education Resource
(ONc-PoWER): An Evaluation of a Web-Enhanced Education Resource for Nurse Practitioners Who Are New to Ca...

Rosemary L. Hoffmann, PhD, RN, CNL, Sara Klein, MS, BSN, RN, Mary Connolly, BSN, RN, and Margaret Quinn Rosenzweig, PhD, FNP-BC, AOCNP®, FAAN



 
Section Seperator

TODAY'S NEWS

Addition of Pazopanib to Paclitaxel in P...

In a phase II trial reported in JAMA Oncology, Ric...

Dual HER2 Inhibition Plus Aromatase Inhi...

The phase III ALTERNATIVE trial demonstrated a pro...

FDA Grants Breakthrough Therapy Designat...

On December 21, the U.S. Food and Drug Administrat...

Activity of Hypoxia-Inducible Factor-2α ...

In a phase I trial reported in the Journal of Clin...

FDA Accepts sNDA, Grants Priority Review...

On December 22, the U.S. Food and Drug Administrat...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Older Patients With Metastatic RCC, Sunitinib

Tom, a 75-year-old white male, was recently diagnosed with metastatic RCC...

Precautions for Patients Taking Tamoxifen

Tamoxifen is a lifesaving treatment for millions of breast cancer patients worldwide...

Pharmaceutical Clinical Educators: A Resource

One of the main challenges within clinical practice today involves attaining the knowledge necessary to treat patients safely and effectively...

Alectinib and Brigatinib: 
ALK Inhibitors for NSCLC

The treatment of non–small cell lung cancer (NSCLC) has been revolutionized by the discovery of...

Diagnostic Snapshot: Tender Nodules of the Foot

The patient is a 56-year-old woman who suffered a significant left foot injury in 2010 when her left foot was crushed in a car accident...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Long-Term Outcomes With Neoadjuvant vs A...

A meta-analysis reported in <em>The Lancet O...

Addition of PEGPH20 to Nab-Paclitaxel/Ge...

In a phase II study reported in the <em>Jour...

Venetoclax in Chronic Lymphocytic Leukem...

An interim analysis of a phase II trial reported b...

FDA Updates Nilotinib Label With Informa...

On December 22, the U.S. Food and Drug Administrat...

FDA Clears Stereotactic Radiotherapy Sys...

On December 22, the U.S. Food and Drug Administrat...

More Highlights More Highlights
Section Seperator

LATEST TWEETS







More Tweets More Tweets
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here